HHS moves to slash funding and access to care for transgender minors

Health Secretary Robert F. Kennedy Jr. has announced new regulations aimed at restricting transition-related care for transgender minors, which includes prohibiting hospitals that accept Medicare and Medicaid from providing such services. This move is part of a broader initiative by the Trump administration to limit access to gender-affirming treatments for youth across the United States.

The U.S. Department of Health and Human Services has announced a series of regulatory actions aimed at effectively banning gender-affirming care for minors, which includes prohibiting Medicaid funding for puberty blockers, hormone treatments, and surgical procedures. This proposal has been met with significant backlash from advocates for LGBTQ+ rights and healthcare professionals.

U.S. officials, under the Trump administration, are proposing new regulations that would effectively ban gender-affirming care for minors, including prohibiting Medicaid funding for treatments such as puberty blockers and hormone therapies. This move has sparked significant concern among healthcare professionals and advocates for LGBTQ+ rights.

The Trump administration has proposed two new rules aimed at banning gender-affirming care for minors, leveraging Medicare and Medicaid regulations to restrict access to treatments for transgender youth. This initiative, announced by RFK Jr. and Dr. Oz, is expected to impact not only those using public insurance but also those with private coverage.

A former leading scientist at the National Institutes of Health (NIH) has filed a lawsuit against the Trump administration, alleging that her termination was illegal and linked to her warnings about the detrimental effects of research funding cuts on public health and patient safety.